Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorbald van Hall

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Oncoimmunology|August 16, 2019
TEIPP peptides: exploration of unTAPped cancer antigensKoen A Marijt, Sjoerd H Van Der Burg, Thorbald van Hall
Cancers|April 16, 2020
Future Challenges in Cancer Resistance to ImmunotherapyMarit J van Elsas, Thorbald van Hall, Sjoerd H van der Burg
Cancer Immunology, Immunotherapy : CII|November 26, 2011
A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigensUrsula J E Seidel, Claudia C Oliveira, Margit H Lampen, et al.
Frontiers in Oncology|February 25, 2025
Improving CD3 bispecific antibody therapy in solid tumors using combination strategiesKaty Lloyd, Jim Middelburg, Vitalijs Ovcinnikovs, et al.
Microbes and Infection|July 31, 2010
The other Janus face of Qa-1 and HLA-E: diverse peptide repertoires in times of stressThorbald van Hall, Claudia C Oliveira, Simone A Joosten, et al.
Current Opinion in Immunology|January 23, 2016
The urgent need to recover MHC class I in cancers for effective immunotherapyFederico Garrido, Natalia Aptsiauri, Elien M Doorduijn, et al.
Cancers|January 20, 2021
Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid TumorsJim Middelburg, Kristel Kemper, Patrick Engelberts, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2021
Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacementKoen A Marijt, Lisa Griffioen, Laura Blijleven, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2012
Effective cooperation of monoclonal antibody and peptide vaccine for the treatment of mouse melanomaLong V Ly, Marjolein Sluijter, Sjoerd H van der Burg, et al.
Nature Reviews. Cancer|March 12, 2016
Vaccines for established cancer: overcoming the challenges posed by immune evasionSjoerd H van der Burg, Ramon Arens, Ferry Ossendorp, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Oncoimmunology|August 16, 2019
TEIPP peptides: exploration of unTAPped cancer antigensKoen A Marijt, Sjoerd H Van Der Burg, Thorbald van Hall
Cancers|April 16, 2020
Future Challenges in Cancer Resistance to ImmunotherapyMarit J van Elsas, Thorbald van Hall, Sjoerd H van der Burg
Cancer Immunology, Immunotherapy : CII|November 26, 2011
A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigensUrsula J E Seidel, Claudia C Oliveira, Margit H Lampen, et al.
Frontiers in Oncology|February 25, 2025
Improving CD3 bispecific antibody therapy in solid tumors using combination strategiesKaty Lloyd, Jim Middelburg, Vitalijs Ovcinnikovs, et al.
Microbes and Infection|July 31, 2010
The other Janus face of Qa-1 and HLA-E: diverse peptide repertoires in times of stressThorbald van Hall, Claudia C Oliveira, Simone A Joosten, et al.
Current Opinion in Immunology|January 23, 2016
The urgent need to recover MHC class I in cancers for effective immunotherapyFederico Garrido, Natalia Aptsiauri, Elien M Doorduijn, et al.
Cancers|January 20, 2021
Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid TumorsJim Middelburg, Kristel Kemper, Patrick Engelberts, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2021
Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacementKoen A Marijt, Lisa Griffioen, Laura Blijleven, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2012
Effective cooperation of monoclonal antibody and peptide vaccine for the treatment of mouse melanomaLong V Ly, Marjolein Sluijter, Sjoerd H van der Burg, et al.
Nature Reviews. Cancer|March 12, 2016
Vaccines for established cancer: overcoming the challenges posed by immune evasionSjoerd H van der Burg, Ramon Arens, Ferry Ossendorp, et al.
Pageof 13